SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-24-002435
Filing Date
2024-01-04
Accepted
2024-01-04 16:06:12
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B5 d625325d424b5.htm 424B5 542756
2 GRAPHIC g625325g00a48.jpg GRAPHIC 30432
3 GRAPHIC g625325g00a91.jpg GRAPHIC 26161
4 GRAPHIC g625325g94j64.jpg GRAPHIC 35104
  Complete submission text file 0001193125-24-002435.txt   667144
Mailing Address 200 ARSENAL YARDS BLVD., SUITE 230 WATERTOWN MA 02472
Business Address 200 ARSENAL YARDS BLVD., SUITE 230 WATERTOWN MA 02472 857-285-5314
Kymera Therapeutics, Inc. (Filer) CIK: 0001815442 (see all company filings)

IRS No.: 812992166 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-259955 | Film No.: 24511836
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)